Market Overview:
Basal cell carcinoma (BCC) is the most common type of skin cancer. BCC arises from the basal cells, which are located in the deepest layer of the epidermis (the outermost layer of skin). The vast majority of BCCs are cured by surgery, radiation therapy, or photodynamic therapy. Drugs such as imiquimod and ingenol mebutate are also used to treat BCC. The global basal cell carcinoma therapeutics market is expected to grow at a CAGR of 5.8% during the forecast period 2018-2030.
Product Definition:
Basal cell carcinoma therapeutics is a treatment for basal cell carcinoma, a type of skin cancer. Basal cell carcinoma is the most common type of skin cancer, and it can often be treated with surgery. However, if the tumor is large or located in a difficult-to-treat location, chemotherapy or radiation therapy may be necessary.
Surgery:
Surgery is the most common treatment for cancer. It's usage and growth factor in the market for Basal Cell Carcinoma Therapeutics is expected to grow at a significant rate over the forecast period. Surgery includes various procedures used to remove or destroy abnormal cells. The two types of surgeries generally performed are open surgery and minimally invasive surgery (MIS).
Radiation Therapy:
Radiation therapy is a treatment that uses high energy rays or particles to destroy the cancer cells. Radiation oncology is used in various types of cancers such as skin, prostate, lung, breast and head & neck. The most common form of radiation oncology employed for the treatment of cancer is Radiotherapy which includes external beam radiation therapy (EBRT), intraoperative radiotherapy (IRBT) and image-guided radiotherapy (IGRT).
Application Insights:
The retail pharmacies segment dominated the market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to growing awareness about early diagnosis and treatment of cancer coupled with increasing availability of affordable healthcare services. Retail pharmacies offer a high level of convenience as they stock a large number of drugs, which helps patients avoid long waiting periods at doctors¢â‚¬â„¢ offices or hospitals. Moreover, these stores provide free consultation services for new customers, which help them understand the benefits and disadvantages associated with various treatments available for different types of cancers.
Hospitals pharmacies are anticipated to register the fastest CAGR during the forecast period owing to rising awareness among hospital staff regarding providing quality healthcare service along with improving infrastructure in developing countries such as India, China Japan etc., These factors are likely to result in increased demand from these institutions over the next few years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in research & development, and availability of technologically advanced products for treatment. Moreover, increasing prevalence of skin cancer is also one of the factors responsible for its largest share. According to statistics published by American Cancer Society in 2018, around 2 million new cases were estimated to be diagnosed in U.S.
Growth Factors:
- Increasing incidence of basal cell carcinoma (BCC)
- Growing awareness about the early diagnosis and treatment of BCC
- Rising demand for better and less invasive treatments for BCC
- Technological advancements in the field of basal cell carcinoma therapeutics 5. Growing investments by pharmaceutical companies in research and development of new drugs for the treatment of BCC
Scope Of The Report
Report Attributes
Report Details
Report Title
Basal Cell Carcinoma Therapeutics Market Research Report
By Type
Surgery, Radiation Therapy, Photodynamic Therapy, Drugs
By Application
Retail Pharmacies, Hospitals Pharmacies, Cancer Research Institutes
By Companies
Sun Pharmaceuticals, Bausch Health, Mylan, F. Hoffmann-La Roche, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
225
Number of Tables & Figures
158
Customization Available
Yes, the report can be customized as per your need.
Global Basal Cell Carcinoma Therapeutics Market Report Segments:
The global Basal Cell Carcinoma Therapeutics market is segmented on the basis of:
Types
Surgery, Radiation Therapy, Photodynamic Therapy, Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Retail Pharmacies, Hospitals Pharmacies, Cancer Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sun Pharmaceuticals
- Bausch Health
- Mylan
- F. Hoffmann-La Roche
- Merck
Highlights of The Basal Cell Carcinoma Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgery
- Radiation Therapy
- Photodynamic Therapy
- Drugs
- By Application:
- Retail Pharmacies
- Hospitals Pharmacies
- Cancer Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Basal Cell Carcinoma Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Basal cell carcinoma (BCC) is a type of skin cancer that can occur on any part of the body. BCC is most commonly found on the face, neck, and upper chest. It can also occur in other parts of the body, such as the hands and feet. BCC is a slow-growing cancer that often does not cause any symptoms until it has progressed to an advanced stage. At this stage, BCC may cause pain or swelling in the area where it has developed. If left untreated, BC
Some of the major companies in the basal cell carcinoma therapeutics market are Sun Pharmaceuticals, Bausch Health, Mylan, F. Hoffmann-La Roche, Merck.
The basal cell carcinoma therapeutics market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Basal Cell Carcinoma Therapeutics Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Basal Cell Carcinoma Therapeutics Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Basal Cell Carcinoma Therapeutics Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Basal Cell Carcinoma Therapeutics Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Basal Cell Carcinoma Therapeutics Market Size & Forecast, 2018-2028 4.5.1 Basal Cell Carcinoma Therapeutics Market Size and Y-o-Y Growth 4.5.2 Basal Cell Carcinoma Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Basal Cell Carcinoma Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Basal Cell Carcinoma Therapeutics Market Size Forecast by Type
5.2.1 Surgery
5.2.2 Radiation Therapy
5.2.3 Photodynamic Therapy
5.2.4 Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Basal Cell Carcinoma Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Basal Cell Carcinoma Therapeutics Market Size Forecast by Applications
6.2.1 Retail Pharmacies
6.2.2 Hospitals Pharmacies
6.2.3 Cancer Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Basal Cell Carcinoma Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Basal Cell Carcinoma Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Basal Cell Carcinoma Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Basal Cell Carcinoma Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Basal Cell Carcinoma Therapeutics Market Size Forecast by Type
9.6.1 Surgery
9.6.2 Radiation Therapy
9.6.3 Photodynamic Therapy
9.6.4 Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Basal Cell Carcinoma Therapeutics Market Size Forecast by Applications
9.10.1 Retail Pharmacies
9.10.2 Hospitals Pharmacies
9.10.3 Cancer Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Basal Cell Carcinoma Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Basal Cell Carcinoma Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Basal Cell Carcinoma Therapeutics Market Size Forecast by Type
10.6.1 Surgery
10.6.2 Radiation Therapy
10.6.3 Photodynamic Therapy
10.6.4 Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Basal Cell Carcinoma Therapeutics Market Size Forecast by Applications
10.10.1 Retail Pharmacies
10.10.2 Hospitals Pharmacies
10.10.3 Cancer Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Basal Cell Carcinoma Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Basal Cell Carcinoma Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Basal Cell Carcinoma Therapeutics Market Size Forecast by Type
11.6.1 Surgery
11.6.2 Radiation Therapy
11.6.3 Photodynamic Therapy
11.6.4 Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Basal Cell Carcinoma Therapeutics Market Size Forecast by Applications
11.10.1 Retail Pharmacies
11.10.2 Hospitals Pharmacies
11.10.3 Cancer Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Basal Cell Carcinoma Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Basal Cell Carcinoma Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Basal Cell Carcinoma Therapeutics Market Size Forecast by Type
12.6.1 Surgery
12.6.2 Radiation Therapy
12.6.3 Photodynamic Therapy
12.6.4 Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Basal Cell Carcinoma Therapeutics Market Size Forecast by Applications
12.10.1 Retail Pharmacies
12.10.2 Hospitals Pharmacies
12.10.3 Cancer Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Basal Cell Carcinoma Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Basal Cell Carcinoma Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Basal Cell Carcinoma Therapeutics Market Size Forecast by Type
13.6.1 Surgery
13.6.2 Radiation Therapy
13.6.3 Photodynamic Therapy
13.6.4 Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Basal Cell Carcinoma Therapeutics Market Size Forecast by Applications
13.10.1 Retail Pharmacies
13.10.2 Hospitals Pharmacies
13.10.3 Cancer Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Basal Cell Carcinoma Therapeutics Market: Competitive Dashboard
14.2 Global Basal Cell Carcinoma Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sun Pharmaceuticals
14.3.2 Bausch Health
14.3.3 Mylan
14.3.4 F. Hoffmann-La Roche
14.3.5 Merck